Skip to main content
. 2024 Jul 15;20(10):3911–3922. doi: 10.7150/ijbs.93697

Figure 1.

Figure 1

Timeline of FDA-approved combination immunotherapies as of April 2024. The timeline shows the first times the FDA approved a certain type of combination and the indication for which the combination was approved. The data is based on the FDA database. https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications. Created with BioRender.com.